Analysts Set Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Price Target at $19.67

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) have earned an average rating of “Moderate Buy” from the seven research firms that are covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation, three have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $19.67.

Several brokerages recently issued reports on SBRA. Scotiabank boosted their target price on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a “sector perform” rating in a research report on Monday, June 23rd. Truist Financial lifted their price target on shares of Sabra Healthcare REIT from $17.00 to $18.00 and gave the stock a “hold” rating in a research note on Tuesday, March 18th.

Sabra Healthcare REIT Stock Up 0.8%

Sabra Healthcare REIT stock opened at $18.62 on Wednesday. Sabra Healthcare REIT has a one year low of $15.11 and a one year high of $20.03. The stock has a fifty day moving average of $17.91 and a 200 day moving average of $17.32. The company has a debt-to-equity ratio of 0.89, a quick ratio of 4.22 and a current ratio of 4.22. The stock has a market cap of $4.43 billion, a PE ratio of 31.55, a price-to-earnings-growth ratio of 1.41 and a beta of 0.85.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $0.37 EPS for the quarter, beating the consensus estimate of $0.36 by $0.01. Sabra Healthcare REIT had a net margin of 19.55% and a return on equity of 5.14%. The firm had revenue of $183.54 million during the quarter, compared to analyst estimates of $180.23 million. During the same quarter in the prior year, the firm earned $0.35 EPS. The business’s revenue for the quarter was up 10.1% compared to the same quarter last year. As a group, sell-side analysts predict that Sabra Healthcare REIT will post 1.45 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 30th. Investors of record on Friday, May 16th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, May 16th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.45%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 203.39%.

Insider Transactions at Sabra Healthcare REIT

In other Sabra Healthcare REIT news, Director Michael J. Foster sold 11,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total transaction of $200,420.00. Following the sale, the director owned 64,725 shares in the company, valued at approximately $1,179,289.50. This trade represents a 14.53% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.20% of the company’s stock.

Institutional Trading of Sabra Healthcare REIT

Hedge funds and other institutional investors have recently modified their holdings of the company. Bank of New York Mellon Corp lifted its stake in shares of Sabra Healthcare REIT by 13.0% during the 4th quarter. Bank of New York Mellon Corp now owns 4,039,651 shares of the real estate investment trust’s stock valued at $69,967,000 after buying an additional 463,601 shares in the last quarter. QRG Capital Management Inc. raised its holdings in Sabra Healthcare REIT by 5.0% during the fourth quarter. QRG Capital Management Inc. now owns 59,983 shares of the real estate investment trust’s stock valued at $1,039,000 after acquiring an additional 2,879 shares during the period. US Bancorp DE lifted its position in shares of Sabra Healthcare REIT by 9.5% in the fourth quarter. US Bancorp DE now owns 22,977 shares of the real estate investment trust’s stock valued at $398,000 after acquiring an additional 1,999 shares in the last quarter. Jones Financial Companies Lllp lifted its position in shares of Sabra Healthcare REIT by 208.3% in the fourth quarter. Jones Financial Companies Lllp now owns 6,222 shares of the real estate investment trust’s stock valued at $108,000 after acquiring an additional 4,204 shares in the last quarter. Finally, Assetmark Inc. boosted its stake in shares of Sabra Healthcare REIT by 33.4% in the fourth quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust’s stock worth $45,000 after acquiring an additional 656 shares during the period. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.